DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial

[1]  David Armstrong,et al.  DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial , 2018, British Medical Journal.

[2]  S. Ruberg,et al.  Estimands in clinical trials – broadening the perspective , 2017, Statistics in medicine.

[3]  Martin Posch,et al.  Determination of the optimal sample size for a clinical trial accounting for the population size , 2016, Biometrical journal. Biometrische Zeitschrift.

[4]  Frank Bretz,et al.  Estimands: discussion points from the PSI estimands and sensitivity expert group , 2017, Pharmaceutical statistics.

[5]  G. Rosenkranz,et al.  Estimands—new statistical principle or the emperor's new clothes? , 2017, Pharmaceutical statistics.

[6]  E. Donnelly.  Guidance for researchers , 2015 .

[7]  Douglas G Altman,et al.  Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers , 2015, Trials.

[8]  P. Fayers,et al.  Assessing methods to specify the target difference for a randomised controlled trial: DELTA (Difference ELicitation in TriAls) review. , 2014, Health technology assessment.

[9]  Douglas G. Altman,et al.  Methods for Specifying the Target Difference in a Randomised Controlled Trial: The Difference ELicitation in TriAls (DELTA) Systematic Review , 2014, PLoS medicine.

[10]  Andrew H Briggs,et al.  Use of methods for specifying the target difference in randomised controlled trial sample size calculations: Two surveys of trialists’ practice , 2014, Clinical trials.

[11]  Leiv Sandvik,et al.  Surgery with disc prosthesis versus rehabilitation in patients with low back pain and degenerative disc: two year follow-up of randomised study , 2011, BMJ : British Medical Journal.

[12]  M. Sharpe,et al.  Comparison of adaptive pacing therapy , cognitive behaviour therapy , graded exercise therapy , and specialist medical care for chronic fatigue syndrome ( PACE ) : a randomised trial , 2013 .

[13]  D. Machin,et al.  Sample Size Calculations for Clinical Trials , 2010 .

[14]  J. Bland,et al.  The tyranny of power: is there a better way to calculate sample size? , 2009, BMJ : British Medical Journal.

[15]  Steven A. Julious,et al.  Sample Sizes for Clinical Trials , 2009 .

[16]  Philippe Ravaud,et al.  Reporting of sample size calculation in randomised controlled trials: review , 2009, BMJ : British Medical Journal.

[17]  A. Copay,et al.  Understanding the minimum clinically important difference: a review of concepts and methods. , 2007, The spine journal : official journal of the North American Spine Society.

[18]  K. Schulz,et al.  Sample size calculations in randomised trials: mandatory and mystical , 2005, The Lancet.

[19]  Stephen Senn,et al.  Controversies concerning randomization and additivity in clinical trials , 2004, Statistics in medicine.

[20]  D. Spiegelhalter,et al.  Disease Mapping With WinBUGS and MLwiN, Bayesian Approaches to Clinical Trials and Health Care Evaluation , 2004 .

[21]  Hamid Pezeshk,et al.  Bayesian techniques for sample size determination in clinical trials: a short review , 2003, Statistical methods in medical research.

[22]  D. Beaton,et al.  Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research. , 2002, Current opinion in rheumatology.

[23]  A Laupacis,et al.  How well is the clinical importance of study results reported? An assessment of randomized controlled trials. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[24]  D. Moher,et al.  The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration , 2001, Annals of Internal Medicine.

[25]  B Shea,et al.  Minimal clinically important differences: review of methods. , 2001, The Journal of rheumatology.

[26]  S. Chinn.  A simple method for converting an odds ratio to effect size for use in meta-analysis. , 2000, Statistics in medicine.

[27]  A Cuschieri,et al.  Sample size calculation for clinical trials: the impact of clinician beliefs , 1999, British Journal of Cancer.

[28]  S. Hollis,et al.  What is meant by intention to treat analysis? Survey of published randomised controlled trials , 1999, BMJ.

[29]  K Claxton,et al.  The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. , 1999, Journal of health economics.

[30]  S. Goodman,et al.  The Use of Predicted Confidence Intervals When Planning Experiments and the Misuse of Power When Interpreting Results , 1994, Annals of Internal Medicine.